Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Eguizabal, Cristina  [Clear All Filters]
Journal Article
Duffin K, Neuhaus N, Andersen CYding, Barraud-Lange V, Braye A, Eguizabal C, Feraille A, Ginsberg JP, Gook D, Goossens E, et al. A 20-year overview of fertility preservation in boys: new insights gained through a comprehensive international survey. Hum Reprod Open. 2024;2024(2):hoae010.
Martin-Iglesias S, Herrera L, Santos S, Vesga MÁngel, Eguizabal C, Lanceros-Méndez S, Silvan U. Analysis of the impact of handling and culture on the expansion and functionality of NK cells. Front Immunol. 2023;14:1225549.
Zenarruzabeitia O, Vitallé J, Eguizabal C, Simhadri VR, Borrego F. The Biology and Disease Relevance of CD300a, an Inhibitory Receptor for Phosphatidylserine and Phosphatidylethanolamine. J Immunol. 2015;194(11):5053-5060.
Czukiewska SM, Fan X, Mulder AA, Van Der Helm T, Hillenius S, Van Der Meeren L, Matorras R, Eguizabal C, Lei L, Koning RI, et al. Cell-cell interactions during the formation of primordial follicles in humans. Life Sci Alliance. 2023;6(11).
Melero I, Molina C, Eguizabal C, Alvarez M. Intratumoral NK cell delivery combined with neutralization of the NKG2A pathway as treatment for solid cancer. Genes Immun. 2024.
Herrera L, Martin-Inaraja M, Bengoetxea A, Vendrell A, Pérez-Fernández S, Eguizabal C, Matorras R. Natural killer cell subsets in endometrial fluid: a pilot study of their association with the endometrial cycle and reproductive parameters. J Assist Reprod Genet. 2023.
Demarta-Gatsi C, Andenmatten N, Jiménez-Díaz M-B, Gobeau N, Cherkaoui-Rabti MH, Fuchs A, Díaz P, Berja S, Sanchez R, Gómez H, et al. Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model. Antimicrob Agents Chemother. 2023:e0157422.
Herrera L, Juan M, Eguizabal C. Purification, Culture, and CD19-CAR Lentiviral Transduction of Adult and Umbilical Cord Blood NK Cells. Curr Protoc Immunol. 2020;131(1):e108.
Gonzaga A, Andreu E, Hernández-Blasco LM, Meseguer R, Al-Akioui-Sanz K, Soria-Juan B, Sanjuan-Gimenez JCarlos, Ferreras C, Tejedo JR, Lopez-Lluch G, et al. Rationale for combined therapies in severe-to-critical COVID-19 patients. Front Immunol. 2023;14:1232472.
Sanchez-Guijo F, Avendaño-Solá C, Badimon L, Bueren JA, Canals JM, Delgadillo J, Delgado J, Eguizabal C, Fernández-Santos M-E, García-Olmo D, et al. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplant. 2023.